Lorentzon, Mattias
Wåhlstrand, Victor
Alvén, Jennifer
Häggström, Ida
Johansson, Lisa https://orcid.org/0009-0005-6005-3838
Funding for this research was provided by:
Vetenskapsrådet
University of Gothenburg
Article History
Received: 13 January 2026
Accepted: 2 May 2026
First Online: 12 May 2026
Declarations
:
: All subjects signed an informed consent prior to participation. The study has been approved by the regional Ethics Review Board in Gothenburg (Dnr 929—12).
: ML has received lecture or consulting fees from Astellas, Amgen, UCB Pharma, Medison Pharma, Sandoz, Gedeon Richter, Jansen-Cilag, Medac, Pharmacosmos, Parexel International, and Crinetics, all outside the submitted work. LJ has received lecture fees from UCB Pharma, all outside the submitted work. All other authors declare no conflicts of interest.